4.91
-0.3099(-5.94%)
Currency In USD
| Previous Close | 5.22 |
| Open | 6.41 |
| Day High | 6.96 |
| Day Low | 4.12 |
| 52-Week High | 702 |
| 52-Week Low | 2.94 |
| Volume | 971,298 |
| Average Volume | 79,616 |
| Market Cap | 2.86M |
| PE | -0.01 |
| EPS | -612.99 |
| Moving Average 50 Days | 4.31 |
| Moving Average 200 Days | 46.14 |
| Change | -0.31 |
If you invested $1000 in Psyence Biomedical Ltd. Common Shares (PBM) since IPO date, it would be worth $1.32 as of June 01, 2025 at a share price of $4.91. Whereas If you bought $1000 worth of Psyence Biomedical Ltd. Common Shares (PBM) shares 1 year ago, it would be worth $1.32 as of June 01, 2025 at a share price of $4.91.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Psyence BioMed Finalizes Agreement with Award-Winning CRO Southern Star Research to Accelerate Phase IIb Clinical Trial
Newsfile
May 27, 2025 11:30 AM GMT
New York, New York--(Newsfile Corp. - May 27, 2025) - Psyence BioMed (NASDAQ: PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company developing nature-derived psilocybin therapies for unmet mental health needs, today announced the fina
Psyence BioMed Announces Effective Date for 1-for-7.97 Reverse Stock Split
Newsfile
May 01, 2025 11:30 AM GMT
New York, New York--(Newsfile Corp. - May 1, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced the effective date of its 1-for-7.97 share consolidation (reverse stock split) of the Company's issued and
Psyence BioMed Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Newsfile
Apr 17, 2025 11:17 PM GMT
New York, New York--(Newsfile Corp. - April 17, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") announced today that it received a notification letter dated April 16, 2025, from the Listings Qualifications Department